FAULKNER DARYL 4
4 · GenMark Diagnostics, Inc. · Filed May 1, 2020
Insider Transaction Report
Form 4
FAULKNER DARYL
Director
Transactions
- Tax Payment
Common Stock
2020-04-29$12.53/sh−6,920$86,708→ 113,318 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-04-29−14,450→ 0 totalExercise: $6.00Exp: 2020-05-28→ Common Stock (14,450 underlying) - Exercise/Conversion
Common Stock
2020-04-29$6.00/sh+14,450$86,700→ 120,238 total
Footnotes (1)
- [F1]The Reporting Person was issued 7,530 shares of the Company's common stock pursuant to the net exercise of the designated stock options. As a result, the Company withheld 6,920 shares of common stock underlying the exercised stock option for the payment of the exercise price using the closing stock price on April 29, 2020 of $12.53 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan.